On October 30, Gelonhui announced the third quarter report for 2024, with the company achieving revenue of 0.219 billion yuan in the first three quarters, a decrease of 2.94% year-on-year; net income attributable to shareholders of the listed company was -3.693 million yuan; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -4.058 million yuan; basic earnings per share was -0.0210 yuan.
赛隆药业(002898.SZ)：前三季度净亏损369.3万元
Sailong Pharmaceutical Group (002898.SZ): a net loss of 3.693 million yuan in the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated